Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...
Merck said on Wednesday that its experimental oral HIV treatment was not inferior to Gilead's top-selling HIV drug Biktarvy ...
11don MSN
New HIV drug has ‘energised the LGBT community’ according to leading charity in Northern Ireland
A new jab, which will help prevent HIV transmissions, has been described as a ‘game changer’ by an LGBT charity in Northern ...
About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...
Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...
Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date.
The United States has begun distributing a groundbreaking HIV-prevention treatment to two African nations, marking a ...
The city's axess sexual health service is piloting a new online platform that will deliver preventative HIV medication PrEP direct to patients without the need for them to have an in-person ...
A new project co-led by Brown researchers is looking to tackle the recent rise in substance abuse, HIV, hepatitis C and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback